Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCAT1 | P54687 | 17/20 | 0.44 |
| ▸ | BCAT2 | O15382 | 15/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8112922 | 1.00 | BCAT1 (0.44) | BCAT1BCAT2SMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL23635730 | 0.89 | BCAT1 (0.40) | BCAT1BCAT2SMN1; SMN2ALDH1A1 | |
| SCHEMBL8105838 | 0.89 | BCAT1 (0.49) | BCAT1BCAT2SMN1; SMN2ALDH1A1 | |
| SCHEMBL8105836 | 0.89 | BCAT1 (0.49) | BCAT1BCAT2SMN1; SMN2ALDH1A1 | |
| SCHEMBL9075035 | 0.86 | BCAT1 (0.44) | BCAT1BCAT2SMN1; SMN2ALDH1A1 | |
| SCHEMBL9367256 | 0.85 | SMN1; SMN2 (0.51) | SMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL7933774 | 0.85 | SMN1; SMN2 (0.51) | SMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL7164163 | 0.84 | BCAT1 (0.50) | BCAT1BCAT2 | |
| SCHEMBL8105366 | 0.83 | BCAT1 (0.48) | BCAT1BCAT2 | |
| SCHEMBL8105362 | 0.83 | BCAT1 (0.48) | BCAT1BCAT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010031865-A1 | Substituted 3-phenyluracils | KLINTZ RALF (DE) | 2001-10-18 | — | — | US | disclosed |
| US-6239074-B1 | HERBICIDES, INSECTICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2001-05-29 | — | — | US | disclosed |
| EP-0716653-B1 | SUBSTITUTED 1-AMINO-3-PHENYLURACILS WITH HERBICIDAL ACTIVITIES | BASF AG (DE) | 2000-04-26 | — | — | EP | disclosed |
| US-5700805-A | HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1997-12-23 | — | — | US | disclosed |
| EP-0716653-A1 | SUBSTITUTED 1-AMINO-3-PHENYLURACILS WITH HERBICIDAL ACTIVITIES | BASF AKTIENGESELLSCHAFT (DE) | 1996-06-19 | — | — | EP | disclosed |
| WO-1995006641-A1 | SUBSTITUTED 1-AMINO-3-PHENYLURACILS WITH HERBICIDAL ACTIVITIES | BASF AKTIENGESELLSCHAFT (DE) | 1995-03-09 | — | — | WO | disclosed |
| EP-0297621-B1 | Cyclic amino-thioacetal amides, a process for the preparation thereof and pharmaceutical compositions containing them | BOEHRINGER MANNHEIM ITALIA (IT) | 1994-09-21 | — | — | EP | disclosed |
| EP-0604491-A1 | SUBSTITUTED 3-PHENYLURACILS AS HERBICIDES | BASF Aktiengesellschaft (DE) | 1994-07-06 | — | — | EP | disclosed |
| WO-1993006090-A1 | SUBSTITUTED 3-PHENYLURACILS AS HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1993-04-01 | — | — | WO | disclosed |
| US-4988701-A | Cyclic amino-thioacetal amides, a process for the preparation thereof and pharmaceutical compositions | BOEHRINGER BIOCHEMIA ROBIN S.P.A. (IT) | 1991-01-29 | — | — | US | disclosed |
| EP-0297621-A2 | Cyclic amino-thioacetal amides, a process for the preparation thereof and pharmaceutical compositions containing them | BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) | 1989-01-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010031865-A1 | Substituted 3-phenyluracils | CCR1, CCR6, CCR3 | BCAT1 139/4885BCAT2 599/4885SMN1; SMN2 4165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.